PAREXEL International

The Quays, 101-105 Oxford Road
UB8 1LZ Uxbridge
United Kingdom

Contact

About PAREXEL International

Parexel is focused on the development of innovative new therapies to improve the world's health. We do this by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

News about PAREXEL International

08-Jan-2019 | business & finance

New PAREXEL division supports emerging biotech companies

PAREXEL International Corporation introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and ...

Read news

08-Mar-2018 | people

PAREXEL appoints Jamie Macdonald as Chief Executive Officer

Company Co-founder Josef von Rickenbach to retire after 35 years

Read news

03-Feb-2017 | business & finance

PAREXEL announces agreement to acquire The Medical Affairs Company

PAREXEL International Corporation, a biopharmaceutical services provider, announced that the Company has entered into a definitive agreement to acquire The ...

Read news

18-Feb-2016 | science

Parexel launches expanded genomic research services

Parexel International Corporation announced expanded services and capabilities in genomic-based drug development. The PAREXEL®Genomic Medicine team offers ...

Read news

04-Jul-2014 | business & finance